DCI

DonaldsonB

NYSE / Capital Goods

At close

2026-07-20

Current thesis

The bull case is supported by record Q3 sales, adjusted EPS growth, all-time high adjusted operating margin, backlog strength, and better Life Sciences guidance. The company also maintained a record adjusted EPS framework despite Facet dilution, which supports the deterministic positive prior.

Posture

Constructive

Lead driver

Value

What changed

Value remains the lead driver in the composite, 7D delta -0.1.

What can break

Adjusted operating margin guidance of 15.8% to 16.2% is below the prior 16.0% to 16.4% range, reflecting gross margin headwinds and integration effects.

Momentum

Value

Sentiment

Setup hits (3d)

0 · Net Neutral

AI TargetsBase $100.00 · Bull $108.00 · Bear $76.00

Data freshness

Prices

As of 2026-07-20

Fundamentals

As of 2026-07-20 • Vendor: Data Vendor v1

Scores

As of 2026-07-20 • Model: HYBRID_IC_RP

AI Memo

As of 2026-06-05 • Model: RankAlpha Sentiment Codex

Investment thesis

As of 2026-07-20

Supporting evidence

What

Grade B · Constructive

Confidence Medium · Net Neutral

Target $100.00

Why

Momentum65 · Δ7d +1.6

Value56 · Δ7d -0.1

Sentiment53 · Δ7d -5.4

So what

Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.

Lead driver: Value · See fundamentals

Momentum

26% active weight

Current posture

7d trendSoftening

Δ7d

+1.6

Δ21d

+26.6

Value

39% active weight

Current posture

7d trendFlat

Δ7d

-0.1

Δ21d

-1.0

Sentiment

34% active weight

Current posture

7d trendSoftening

Δ7d

-5.4

Δ21d

-4.0

Why this grade

Composite grade B. Momentum 64.6 / Value 56.2 / Sentiment 53.0

Fundamentals (TTM)

As of 2026-07-20

Market Cap

$10.39B

Beta

1.01

Shares Out

115.91M

P/E (TTM)

28.4

P/S (TTM)

2.82

P/FCF (TTM)

39.04

Rev YoY

+5.9%

EPS YoY

+108.1%

Gross Margin

+34.3%

Op Margin

+13.8%

Net Debt

$549.8M

Current Ratio

2.35

As of 2026-07-20 • Updated nightlySource: Internal modelMethodology